BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Press Releases

  Sibel Health Announces Close of New Series C Financing and New FDA 510(k) Clearance

  March 20, 2025

   · 

  3 min read
• Press Releases

  Precision BioSciences Presents Preclinical Safety and Efficacy Data Supporting Repeat Dosing of PBGENE-HBV With a Goal of Curing Chronic Hepatitis B at the Global Hepatitis Summit 2025

  March 20, 2025

   · 

  11 min read
• Press Releases

  MiNA Therapeutics Appoints Norbert Bischofberger, Ph.D., to its Board as Non-Executive Director and Bríd Ryan, Ph.D., MPH, as Chief Scientific Officer

  March 20, 2025

   · 

  2 min read
• Press Releases

  Plus Therapeutics Introduces REYOBIQ™, FDA-Accepted Proprietary Name for Lead Drug Candidate

  March 20, 2025

   · 

  2 min read
• Press Releases

  InnoCare Announces First Patient Dosed in the Phase III Registrational Trial of ICP-488 for the Treatment of Psoriasis in China

  March 20, 2025

   · 

  3 min read
• Press Releases

  CorVista Health to Present New Data on Non-Invasive Point of Care Test for Pulmonary Capillary Wedge Pressure Elevation Using Machine Learning at ACC.25

  March 20, 2025

   · 

  2 min read
• Press Releases

  Invivyd Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Recent Business Highlights

  March 20, 2025

   · 

  18 min read
• Press Releases

  VYNE Therapeutics to Participate in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference

  March 20, 2025

   · 

  1 min read
• Press Releases

  Currax Secures Reliable and Consistent Supply of CONTRAVE®/MYSBIMA with FDA Approval for Second Manufacturing Site

  March 20, 2025

   · 

  8 min read
• Press Releases

  GE HealthCare launches AI-driven, patient-friendly Invenia ABUS Premium to accelerate scanning and drive early cancer detection in dense breasts

  March 20, 2025

   · 

  6 min read